Formerly known as OmniCorder Technologies Inc. Advanced BioPhotonics Inc. is engaged in advanced medical imaging technology for the diagnosis and management of a large range of diseases, including cancer and vascular disease. and abnormal tissues by detecting very small changes in perfusion. In December 2011, Sinclair IS Pharma plc acquired Advanced BioPhotonics Inc Advacned BioPhotincs lead product BioScanIR uses an infrared sensor, called a Quantum Well Infrared Photodetector (QWIP). The product has received United States Food & Drug Administration (FDA) clearance permitting its sale of BioScanIR in the United States.. he Companys lead product, the BioScanIR system, detects diseases that affect the perfusion or reperfusion (movement or flow) of blood in tissues and organs. Diseases, such as cancer and vascular disease affect perfusion. The BioScanIR system assists physicians and researchers in differentiating between normal and abnormal tissues by detecting very small changes in perfusion. The BioScanIR uses an infrared sensor, called a Quantum Well Infrared Photodetector (QWIP). It has received United States Food & Drug Administration (FDA) clearance permitting its sale of BioScanIR in the United States.
